Frequency of islet autoantibody seropositivity among adults with newly diagnosed type 2 diabetes in the Kazakh population: A cross‐sectional study
Journal of Diabetes Investigation · 2026-06 · 17 (6) · 970-978
DOI: 10.1111/jdi.70312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 21.04.2026. Verfasst von Khatimya Kudabayeva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Diseases № 1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan. Hauptthemen laut MEDLINE: Autoantibodies, Diabetes Mellitus, Type 2, Biomarkers, Islets of Langerhans. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: West Kazakhstan Marat Ospanov Medical University,.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims/Introduction Type 2 diabetes mellitus (T2DM) is a heterogeneous condition, and a proportion of patients show autoimmune features consistent with latent autoimmune diabetes in adults (LADA). This study assessed the prevalence of islet autoantibodies in newly diagnosed T2DM patients of Kazakh ethnicity. Materials and Methods A cross‐sectional study was conducted in 240 patients (30–75 years) with newly diagnosed T2DM in the Aktobe region, Kazakhstan (May 2024–January 2025). Clinical data, HbA1c, and fasting C‐peptide were measured. Autoantibodies (GADA, ZnT8A, IA‐2A, ICA‐ELISA) were determined by ELISA. Results Overall, 25.8% of patients were positive for at least one islet autoantibody. ZnT8A (13.3%) and GADA (5.8%) were the most frequent, while IA‐2A and ICA‐ELISA were rare (0.8% each). Double positivity was observed in 4.6% of patients, and triple positivity in 0.4%. GADA was associated with lower BMI (kg/m 2 ), higher HbA1c, and reduced C‐peptide, while ZnT8A was linked to lower C‐peptide. Logistic regression confirmed C‐peptide as the main predictor of autoantibody positivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Diseases № 1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan.
- Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Moldova.
ORCID-Profile: Bibigul Tleumagambetova
Förderung
- West Kazakhstan Marat Ospanov Medical University,
Zitieren
APA
Kudabayeva, K., Tleumagambetova, B., Bazargaliyev, Y., & Vudu, L. (2026). Frequency of islet autoantibody seropositivity among adults with newly diagnosed type 2 diabetes in the Kazakh population: A cross‐sectional study. Journal of Diabetes Investigation, 17(6), 970-978. https://doi.org/10.1111/jdi.70312
Vancouver
Kudabayeva K, Tleumagambetova B, Bazargaliyev Y, Vudu L. Frequency of islet autoantibody seropositivity among adults with newly diagnosed type 2 diabetes in the Kazakh population: A cross‐sectional study. Journal of Diabetes Investigation. 2026;17(6):970-978. doi:10.1111/jdi.70312
BibTeX
@article{Kudabayeva2026,
author = {Kudabayeva, Khatimya and Tleumagambetova, Bibigul and Bazargaliyev, Yerlan and Vudu, Lorina},
title = {Frequency of islet autoantibody seropositivity among adults with newly diagnosed type 2 diabetes in the Kazakh population: A cross‐sectional study},
journal = {Journal of Diabetes Investigation},
year = {2026},
volume = {17},
number = {6},
pages = {970--978},
doi = {10.1111/jdi.70312}
}
EUVIMED